PROCESS FOR TREATMENT OF PSORIASIS

• US 20100256550A1
• Filed: 04/02/2010
• Published: 10/07/2010
• Est. Priority Date: 11/30/1998
• Status: Active Grant

• Current Assignee: David Mcdaniel
• Original Assignee: David Mcdaniel
• Inventors: McDaniel, David
• Granted Patent: US 8,651,112 B2
• Time in Patent Office: Days
• US Class Current: 604/20
• CPC Class Codes: A61B 18/203 applying laser energy to the outside of the body
• CPC Class Codes: A61B 2017/00765 Decreasing the barrier function of skin tissue by radiated energy, e.g. using ultrasound, using laser for skin perforation
• CPC Class Codes: A61B 2017/22085 light-absorbing A61B2017/22087 takes precedence
• CPC Class Codes: A61B 2018/00452 Skin
• CPC Class Codes: A61B 2018/00476 Hair follicles
• CPC Class Codes: A61B 2018/1807 using light other than laser radiation
• CPC Class Codes: A61N 2005/0652 Arrays of diodes
• CPC Class Codes: A61N 5/0617 Hair treatment
• CPC Class Codes: A61N 5/062 Photodynamic therapy, i.e. excitation of an agent

Abstract

A system for producing preferential damage to hair exiting mammalian skin. A agent having an average diameter for enabling the agent to penetrate the hair duct is selected. The agent is designed to attach to, or become physically incorporated into, the hair shaft, the hair follicle, the hair bulb or the hair duct. The agent has an electromagnetic radiation absorption characteristic which enables the agent to absorb a first wavelength of electromagnetic radiation from a skin-penetrating electromagnetic radiation source, such as a laser. The agent is applied to the skin so that the agent penetrates the skin and attaches to or becomes physically incorporated into the hair shaft, the hair follicle, the hair bulb or the hair duct. The agent is exposed to the first wavelength of electromagnetic radiation and absorbs the first wavelength of electromagnetic radiation.

Claims

1. A process for the treatment of psoriasis affecting mammalian skin, comprising:

selecting at least one of a photoactive agent and a photosensitizing agent, the agent having an electromagnetic radiation absorption characteristic enabling the agent to absorb at least a first wavelength of electromagnetic radiation from an electromagnetic radiation source,

applying the agent to at least a portion of the mammalian skin affected by psoriasis, and

exposing the agent substantially simultaneously to electromagnetic radiation comprising at least the first wavelength of electromagnetic radiation to activate the agent and to electromagnetic radiation comprising at least a second wavelength of electromagnetic radiation to treat the psoriasis, whereby the agent absorbs the first wavelength of electromagnetic radiation.

2. The process of claim 1, wherein the electromagnetic radiation source produces an energy fluence of from about 1.0 J/cm² to about 10 J/cm².

3. The process of claim 1, comprising exposing the agent to a second source of electromagnetic radiation.

4. The process of claim 1, comprising exposing the agent to ultrasound.

5. The process of claim 1, wherein the electromagnetic radiation source is at least one light emitting diode.

6. The process of claim 1, comprising exposing the agent to the first wavelength of electromagnetic radiation and to the second wavelength of electromagnetic radiation through the same optics.

7. The process of claim 3, wherein the second source of electromagnetic radiation provides the second wavelength of electromagnetic radiation.